C4 Therapeutics (CCCC) FCF Margin Growth (3y) (2022 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) FCF Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -3,088.00 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 14,060.00 |
| 10 | C4 Therapeutics | 492.73 Mn | 239.06 Mn | - | 70,243.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70,243.00 |
| Mar 31, 2026 | 40,911.00 |
| Dec 31, 2025 | 87,168.00 |
| Sep 30, 2025 | 14,518.00 |
| Jun 30, 2025 | -827.00 |
| Mar 31, 2025 | -11,014.00 |
| Dec 31, 2024 | -21,790.00 |
| Sep 30, 2024 | 5,897.00 |
| Jun 30, 2024 | 14,554.00 |
| Mar 31, 2024 | -25,069.00 |
| Dec 31, 2023 | -47,619.00 |
| Sep 30, 2023 | -10,897.00 |
| Jun 30, 2023 | -57,690.00 |
| Mar 31, 2023 | -64,968.00 |
| Dec 31, 2022 | -94,818.00 |